L

Standard BioTools
D

LAB

1.18500
USD
-0.09
(-6.69%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
428,072,088
Open Account Now أصول ذات صلة
A
A
-0.320
(-0.27%)
119.140 USD
ABT
ABT
0.650
(0.49%)
134.320 USD
ALGN
ALGN
0.820
(0.44%)
188.550 USD
BDX
BDX
0.890
(0.52%)
170.860 USD
IDXX
IDXX
3.13
(0.59%)
531.06 USD
ILMN
ILMN
0.630
(0.67%)
94.840 USD
MRK
MRK
0.170
(0.22%)
79.070 USD
PODD
PODD
3.45
(1.11%)
313.02 USD
REGN
REGN
0.06
(0.01%)
521.05 USD
TMO
TMO
-3.99
(-0.97%)
408.27 USD
T
TNDM
-0.180
(-0.94%)
18.920 USD
ZTS
ZTS
0.408
(0.26%)
156.170 USD
المزيد
الأخبار المقالات

العنوان: Standard BioTools

القطاع: Healthcare
الصناعة: Medical Devices
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.